About NRG Oncology/RTOG 1112
NRG Oncology/RTOG 1112 - Randomized Phase III Study of Sorafenib versus Stereotactic Body Radiation Therapy followed by Sorafenib in Hepatocellular Carcinoma This app is intended to be a quick reference resource for...
NRG Oncology/RTOG 1112 - Randomized Phase III Study of Sorafenib versus Stereotactic Body Radiation Therapy followed by Sorafenib in Hepatocellular Carcinoma
This app is intended to be a quick reference resource for physicians. It does NOT replace the full-length protocol. All activities related to the trial must adhere to the official protocol (RTOG1112) which can be found on the CTUS website (www.ctsu.org) and the NRG website (http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=1112).
Previous Versions
Here you can find the changelog of NRG Oncology/RTOG 1112 since it was posted on our website on 2016-11-02 16:55:39.
The latest version is 1.0 and it was updated on 2024-04-22 15:02:11. See below the changes in each version.
NRG Oncology/RTOG 1112 version 1.0
Updated At: 2015-05-30
Changes: Updated Icons
Disclaimer
External Download
We do not host NRG Oncology/RTOG 1112 on our servers. We did not scan it for viruses, adware, spyware or other type of malware. This app is hosted by Galad and passed their terms and conditions to be listed there. We recommend caution when installing it.
The APK Download link for NRG Oncology/RTOG 1112 is provided to you by apps112.com without any warranties, representations or guarantees of any kind, so access it at your own risk.
If you have questions regarding this particular app contact the publisher directly. For questions about the functionalities of apps112.com contact us.
